Checkmate Pharmaceuticals

Developing a new approach for cancer immunotherapy.

Launch date

2015

Employees

Market cap

Enterprise valuation

Cambridge Massachusetts (HQ)

Date	Investors	Amount	Round
-	Eight Roads Ventures BrightEdge	N/A	-
Aug 2015	Sofinnova Partners venBio Partners Sofinnova Ventures	$20.0m	Series A
Jun 2017	F-Prime venBio Partners Sofinnova Ventures	$27.0m	Series B
Dec 2018*	F-Prime Decheng Capital venBio Partners Sofinnova Ventures	$22.0m	Late VC
Jan 2020	N/A	$16.0m	Early VC
Jun 2020	Novo Holdings Sectoral Asset Management Clough Capital Partners Omega Funds F-Prime Decheng Capital Longitude Capital venBio Partners Novo Seeds Medicxi Ventures Sofinnova Ventures BrightEdge	$85.0m	Series C
Apr 2022*	Regeneron Pharmaceuticals	$250m	Acquisition
Total Funding		€155m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Checkmate Pharmaceuticals